[go: up one dir, main page]

KR900004935A - 슈도 모나즈 아에루기노사의 지질단백질 i(ompi) - Google Patents

슈도 모나즈 아에루기노사의 지질단백질 i(ompi) Download PDF

Info

Publication number
KR900004935A
KR900004935A KR1019890012623A KR890012623A KR900004935A KR 900004935 A KR900004935 A KR 900004935A KR 1019890012623 A KR1019890012623 A KR 1019890012623A KR 890012623 A KR890012623 A KR 890012623A KR 900004935 A KR900004935 A KR 900004935A
Authority
KR
South Korea
Prior art keywords
lipoprotein
ompi
protein
pseudomonas aeruginosa
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1019890012623A
Other languages
English (en)
Inventor
두헤네 미카엘
폰 스페흐트 울리히
돔데이 호르스트
Original Assignee
필립 스타인
베링베르케 아크티엔게젤샤프트
헤리베르트 부흐
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 필립 스타인, 베링베르케 아크티엔게젤샤프트, 헤리베르트 부흐 filed Critical 필립 스타인
Publication of KR900004935A publication Critical patent/KR900004935A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)

Abstract

내용 없음

Description

슈도모나즈 아에루기노사의 지질단백질 I (OMPI)
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 표1에 나타낸 아미노산 서열을 갖는 슈도모나즈 아에루기노사(Pseudomonas aeruginosa)의 외막 단백질(지질단백질) I(OMPI).
  2. 제1항에 따른 지질단백질 I 을 암호화하는 DNA.
  3. 제1항에 따른 지질단백질 I (OMPI)의 면역원성 부분-서열.
  4. 원핵세포 또는 진핵세포에서 표 1에 나타낸 OMPI 또는 면역원성 부분-서열을 암호화하는 DNA를 발현시킴을 특징으로 하여, 상기 OMPI 또는 면역원성 부분-서열을 제조하는 방법.
  5. 항원으로서 제1항에 따른 지질단백질 I 또는 제3항에 따른 지질단백질 I의 면역원성 부분-서열을 사용하여 수득된 폴리클로날 또는 모노클로날 항체.
  6. 제5항에 따른 항체를 함유하는 진단 보조제.
  7. 제2항에 따른 뉴클레오타이드 서열을 전부 또는 일부 함유하거나, 이로부터 유도된 뉴클레오타이드 서열을 함유하는 진단 보조제.
  8. 제6항 또는 7항에 따른 진단 보조제를 사용하는 진단 방법.
  9. 림프구를 유도하여 항체를 생성하기 위한 제1항 또는 3항에 따른 단백질의 용도.
  10. 제1항 또는 3항에 따른 단백질에 대한 항체의 생성을 위한 림프구를 시험하기 위한 제1항 또는 3항의 단백질의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890012623A 1988-09-01 1989-09-01 슈도 모나즈 아에루기노사의 지질단백질 i(ompi) Abandoned KR900004935A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3829616A DE3829616C2 (de) 1988-09-01 1988-09-01 Lipoprotein I (OMPI) von Pseudomonas aeruginosa
DEP3829616.0 1988-09-01

Publications (1)

Publication Number Publication Date
KR900004935A true KR900004935A (ko) 1990-04-13

Family

ID=6362019

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890012623A Abandoned KR900004935A (ko) 1988-09-01 1989-09-01 슈도 모나즈 아에루기노사의 지질단백질 i(ompi)

Country Status (10)

Country Link
US (1) US5550223A (ko)
EP (1) EP0357024A3 (ko)
JP (4) JP3468242B2 (ko)
KR (1) KR900004935A (ko)
AU (1) AU625740B2 (ko)
CA (1) CA1341020C (ko)
DE (1) DE3829616C2 (ko)
DK (1) DK431489A (ko)
FI (1) FI894062A7 (ko)
PT (1) PT91599B (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100468455B1 (ko) * 2000-12-19 2005-01-29 주식회사 포스코 열간특성이 우수한 성형탄
KR101008077B1 (ko) * 2008-10-23 2011-01-13 주식회사 포스코 코크스 제조용 석탄의 배합을 통한 코크스 제조방법

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1112356A (zh) * 1993-06-07 1995-11-22 第一制糖株式会社 新型的减毒铜绿假单胞菌菌株
DE69515613T2 (de) * 1994-12-16 2000-11-30 Chiron Behring Gmbh & Co. Immunogenes Hybridprotein OprF-Oprl erhältlich aus Membranproteinen von Pseudomonas aeruginosa
KR100461710B1 (ko) * 1997-09-13 2005-09-28 씨제이 주식회사 신규한 녹농균 세포 외막 단백질 유전자 및 이를 이용한 녹농균 감염 예방용 백신 및 녹농균 감염증 치료제
GB9918038D0 (en) * 1999-07-30 1999-09-29 Smithkline Beecham Biolog Novel compounds
GB9918302D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Novel compounds
GB9918208D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Novel compounds
CA2400495A1 (en) * 2000-02-18 2001-08-23 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens
US6887493B2 (en) * 2000-10-25 2005-05-03 Adi Shefer Multi component controlled release system for oral care, food products, nutraceutical, and beverages
EP3317295B1 (en) 2015-07-04 2022-05-18 Evaxion Biotech A/S Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa
WO2018127545A1 (en) 2017-01-05 2018-07-12 Evaxion Biotech Aps Vaccines targeting pseudomonas aeruginosa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
JPS5929622A (ja) * 1982-08-10 1984-02-16 Meiji Seika Kaisha Ltd モノクロ−ナル抗体、その製造法およびその用途

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100468455B1 (ko) * 2000-12-19 2005-01-29 주식회사 포스코 열간특성이 우수한 성형탄
KR101008077B1 (ko) * 2008-10-23 2011-01-13 주식회사 포스코 코크스 제조용 석탄의 배합을 통한 코크스 제조방법

Also Published As

Publication number Publication date
CA1341020C (en) 2000-06-06
JP4204607B2 (ja) 2009-01-07
JPH02163088A (ja) 1990-06-22
AU4098489A (en) 1990-04-05
DE3829616C2 (de) 1996-08-29
EP0357024A3 (de) 1990-09-12
FI894062L (fi) 1990-03-02
JP2006328077A (ja) 2006-12-07
EP0357024A2 (de) 1990-03-07
DE3829616A1 (de) 1990-03-15
AU625740B2 (en) 1992-07-16
JP3468242B2 (ja) 2003-11-17
FI894062A0 (fi) 1989-08-30
US5550223A (en) 1996-08-27
DK431489D0 (da) 1989-08-31
PT91599A (pt) 1990-03-30
PT91599B (pt) 1995-05-04
FI894062A7 (fi) 1990-03-02
JP2000152794A (ja) 2000-06-06
JP2005060405A (ja) 2005-03-10
DK431489A (da) 1990-03-02

Similar Documents

Publication Publication Date Title
KR900009095A (ko) 합성 항원, 이의 제조방법 및 용도
BR9710968A (pt) Antìgenos de célula b humana; reagentes correlatos
KR890000517A (ko) 하이브리드 단백질 c 및 이의 제조방법
DK609985A (da) Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
FI891012A0 (fi) Menetelmä ja väline immuunikokeissa esiintyvien häiriötekijöiden kompensoimiseksi
ES8506902A1 (es) Un procedimiento para la purificacion de un antigeno.
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
KR900004935A (ko) 슈도 모나즈 아에루기노사의 지질단백질 i(ompi)
EP0247730A3 (en) Antibodies, their preparation and use and products containing them
SE8704185D0 (sv) Nya peptider, artificiella antigener och immunoanalystestsatser
KR910012244A (ko) 톡소플라스마 곤디 항원, 이의 제조방법 및 이의 용도
DK196282A (da) Fremgangsmaade samt kit til bestemmelse af antistoffer mod oploeselige antigener
NO843591L (no) Fremgangsmaate for aa bestemme pivka-ii-innhold i blodplasma og middel for utfoerelse av denne
DE68921360D1 (de) Monoklonale Antikörper von Mäusen gegen das gp41 Protein von menschlichem Immunmangelsyndrom-Virus.
SE7704359L (sv) Forfarande for anrikning av ett placentaspecifikt glykoprotein
ES8604693A1 (es) Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico.
KR890008316A (ko) 항응고성 단백질 pp4-x, 및 이의 제조방법 및 용도
EP0276984A3 (en) Measuring anti-dna antibodies
KR930004458A (ko) 설폰화 중합체에 대한 모노클로날 항체
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
DK414386A (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
FI86255B (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
DE69011879D1 (de) Immuntestverfahren für zelluläres Eiweiss.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19890901

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19940830

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19890901

Comment text: Patent Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 19970806

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19971020

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19980130

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee